CIK: 0001559565
Total reported value
$183.2M
Reporting period: 2017-12-31 · Number of holdings: 8
Sofinnova Management VIII, L.L.C. disclosed 8 holdings in its latest 13F filing for the period ending 2017-12-31, with total reported value of $183.2M and a quarterly turnover rate of 47.6%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "S"
Sector classification currently covers about 8% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add 67022C106
+600.0% $34.9M
Trim ONCEEUR
0.0% -$18.2M
Add H5861P103
+26.7% $15.8M
Trim NTRA
0.0% -$6.0M
Trim ACRS
0.0% -$1.8M
Trim 87166L100
0.0% -$4.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Nucana PLC Sponsored Adr | Stock-Other | 25.76% | +18.29% | +600.00% | |
| 2 | ✓ | Obseva SA | Stock-Other | 25.31% | +6.70% | +26.67% | |
| 3 | ACRS | Aclaris Therapeutics INC | Stock-Other | 20.72% | -3.51% | — | |
| 4 | ONCEEUR | Spark Therapeutics INC | Stock-Other | 13.51% | -12.65% | — | |
| 5 | NTRA | Natera INC | Stock-Healthcare | 7.61% | -4.57% | — | |
| 6 | ✓ | Auris Med Hldg AG | Stock-Other | 2.52% | -1.39% | — | |
| 7 | ✓ | Histogenics CORP | Stock-Other | 2.32% | -0.19% | — | |
| 8 | ✓ | Synlogic INC | Stock-Other | 2.25% | -2.68% | — |
Not enough priced holdings yet to compute performance
Sofinnova Management VIII, L.L.C.'s most significant position changes for 2017-12-31: Add: Nucana PLC Sponsored Adr — shares +600.00%; Add: Obseva SA — shares +26.67%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Nucana PLC Sponsored Adr | +18.3% | +600.00% | Add |
| 2 | ✓ | Obseva SA | +6.7% | +26.67% | Add |
| 3 | ✓ | Histogenics CORP | -0.2% | — | Unchanged |
| 4 | ✓ | Auris Med Hldg AG | -1.4% | — | Unchanged |
| 5 | ✓ | Synlogic INC | -2.7% | — | Unchanged |
| 6 | ACRS | Aclaris Therapeutics INC | -3.5% | — | Unchanged |
| 7 | NTRA | Natera INC | -4.6% | — | Unchanged |
| 8 | ONCEEUR | Spark Therapeutics INC | -12.7% | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-10-11 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-07-19 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-04-10 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001910205
Total reported value
$183.2M
61 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001912314
Total reported value
$183.3M
69 stks
2023-12-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0002134831
Total reported value
$183.3M
102 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0000884300
Total reported value
$106.7M
86 stks
2026-03-31
1 of the top 5 holdings overlap, including Natera INC
CIK 0001103887
Total reported value
$1.8B
52 stks
2026-03-31
1 of the top 5 holdings overlap, including Natera INC
CIK 0001512173
Total reported value
$2.8B
190 stks
2026-03-31
1 of the top 5 holdings overlap, including Natera INC